eb-203
Small moleculeexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 29, 2022 (NCT05538949)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06487039 | Phase 2 | Aug 1, 2024 | EyebioKorea, Inc., Inje University, Kim's Eye Hospital, Seoul, South Korea, Pusan National University, Yeungnam University |
| NCT05538949 | Phase 1 | Jun 29, 2022 | EyebioKorea, Inc., Inje University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| EyebioKorea, Inc. | For profit | 2 | 2 | 2 | 2022 |
| Inje University | Academic/Hospital | 2 | 0 | 2 | 2022 |
| Kim's Eye Hospital, Seoul, South Korea | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Pusan National University | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Yeungnam University | Academic/Hospital | 1 | 0 | 1 | 2024 |
5 organizations
Page 1 / 1